Author

N. Subramanian

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1 Pharmacology & Toxicology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 3 Approach:statistical model· 3 Research Focus:drug response / drug discovery· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Approach:deep learning· 1

Frequent Co-Authors

J. R. Heath· 2 shared A. Adak· 1 shared A. Aderem· 1 shared A. Magis· 1 shared A. Oliveira Gomes· 1 shared A. Rothchild· 1 shared A. S. Akhade· 1 shared A. Xu· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. R. Heath

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Dual blockade of misfolded alpha-sarcoglycan degradation by bortezomib and givinostat combination

L. Hoch, N. Bourg, F. Degrugillier, C. Bruge, M. Benabides, E. Pellier, J. Tournois, G. Mahe, N. Maignan, J. Dawe, M. Georges, D. Papazian, N. Subramanian, S. Simon, P. Fanen, , X. Nissan

This study identifies givinostat as a potential therapeutic for LGMD R3 by inhibiting autophagy and enhancing bortezomib's effect on misfolded alpha-sarcoglycan degradation.

bioRxiv · Mar 16, 2022Pharmacology & Toxicology

Validation of Functional Polymorphisms Affecting Maize Plant Height by Unoccupied Aerial Systems (UAS) allows Novel Temporal Phenotypes

A. Adak, S. C. Murray, C. Conrad, Y. Chen, S. Anderson, N. Subramanian, S. Wilde

The paper validates two maize PHT QTVs using UAS to show their dynamic effects across genetic backgrounds and growth stages, revealing overlooked phenotypic variability.

bioRxiv · Sep 30, 2020Plant Biology

Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection Trajectories

Y. Su, D. Chen, C. Lausted, D. Yuan, J. Choi, C. Dai, V. Voillet, K. Scherler, P. Troisch, V. R. Duvvuri, P. Baloni, G. Qin, B. Smith, S. Kornilov, C. Rostomily, , the

This study integrates multi-omic data from COVID-19 patients to identify immune response patterns linked to disease severity.

bioRxiv · Jul 27, 2020 · PreprintImmunology

Antibody-Recruiting Protein-Catalyzed Capture Agents to Combat Antibiotic-Resistant Bacteria

M. N. Idso, A. S. Akhade, M. L. Arrieta-Ortiz, B. T. Lai, V. Srinivas, J. P. Hopkins, A. Oliveira Gomes, N. Subramanian, N. Baliga, J. R. Heath

This paper develops AR-PCCs, a computational and synthetic approach, to rapidly create targeted antibiotics against drug-resistant bacteria by leveraging macrocyclic peptide ligands and antibody recruitment.

bioRxiv · Oct 29, 2019Bioengineering